InvestorsHub Logo
Followers 16
Posts 4525
Boards Moderated 0
Alias Born 10/04/2006

Re: None

Thursday, 05/29/2008 1:35:58 PM

Thursday, May 29, 2008 1:35:58 PM

Post# of 386038
Today, many play with BIOTEX. A lot is expected from them. Good picks: OSIP (data on their drug Tarceva, presented at ASCO in Chicago), GILD (phase III news), VRTX (reconsidered as the best performer against hepatitis C), CBST (confirmation of commitment of MIT to them) and DNA & CELG (for no obvious reason). Slightly up but disappointing: AMLN (in spite of pumping by Pete Najarian).


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SPY News